These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31990337)

  • 1. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
    Martinez SC; Mohamed M; Potts J; Abhishek A; Roddy E; Savage M; Bharadwaj A; Kwok CS; Bagur R; Mamas MA
    Rheumatology (Oxford); 2020 Sep; 59(9):2512-2522. PubMed ID: 31990337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Myocardial Infarction in Autoimmune Rheumatologic Disease: A Nationwide Analysis of Clinical Outcomes and Predictors of Management Strategy.
    Mohamed MO; Roddy E; Ya'qoub L; Myint PK; Al Alasnag M; Alraies C; Clarson L; Helliwell T; Mallen C; Fischman D; Al Shaibi K; Abhishek A; Mamas MA
    Mayo Clin Proc; 2021 Feb; 96(2):388-399. PubMed ID: 33248709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital outcomes and trends of patients with autoimmune diseases undergoing percutaneous coronary intervention: A nationwide analysis.
    Antia A; Aomreore K; Udongwo N; Menon S; Ibebuogu U
    Cardiovasc Revasc Med; 2024 Aug; 65():37-43. PubMed ID: 38531708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.
    Lai CH; Lai WW; Chiou MJ; Lin WC; Yang YJ; Li CY; Tsai LM
    Ann Rheum Dis; 2016 Jul; 75(7):1350-6. PubMed ID: 26286017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.
    Sagheer S; Deka P; Pathak D; Khan U; Zaidi SH; Akhlaq A; Blankenship J; Annis A
    Curr Probl Cardiol; 2022 Nov; 47(11):101086. PubMed ID: 34936910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
    Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of familial aggregation of autoimmune rheumatic diseases in Asian Indian patients with systemic lupus erythematosus.
    Ganapati A; Arunachal G; Arya S; Shanmugasundaram D; Jeyaseelan L; Kumar S; Danda S; Danda D
    Rheumatol Int; 2019 Dec; 39(12):2053-2060. PubMed ID: 31263994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study.
    Panopoulos S; Tektonidou M; Drosos AA; Liossis SN; Dimitroulas T; Garyfallos A; Sakkas L; Boumpas D; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Vassilopoulos D; Sfikakis PP
    Arthritis Res Ther; 2018 Dec; 20(1):267. PubMed ID: 30514359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis).
    Borovac JA; Kwok CS; Iliescu C; Lee HJ; Kim PY; Palaskas NL; Zaman A; Butler R; Lopez-Mattei JC; Mamas MA
    Am J Cardiol; 2019 Oct; 124(8):1190-1197. PubMed ID: 31395298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of hemorrhagic stroke in patients with autoimmune rheumatic diseases: An analysis of the US Nationwide Inpatient Sample.
    Chen MY; Chen PY; Chang CN; Chen BA; Deng WC; Yan JL
    Int J Rheum Dis; 2023 Nov; 26(11):2206-2213. PubMed ID: 37726980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.
    Van Doornum S; Bohensky M; Tacey MA; Brand CA; Sundararajan V; Wicks IP
    Arthritis Res Ther; 2015 Feb; 17(1):38. PubMed ID: 25879786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Impact of Type 1 and Type 2 Diabetes Mellitus on Outcomes Among 1.4 Million US Patients Undergoing Percutaneous Coronary Intervention.
    Matetic A; Doolub G; Bharadwaj A; Osman M; Biondi-Zoccai G; Ullah W; Bagur R; Velagapudi P; Alraies MC; Mohamed MO; Mamas MA
    Cardiovasc Revasc Med; 2022 May; 38():83-88. PubMed ID: 34446373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus.
    Thorburn CM; Ward MM
    Arthritis Rheum; 2003 Sep; 48(9):2519-23. PubMed ID: 13130471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of coronary calcification in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Yiu KH; Mok MY; Wang S; Ooi GC; Khong PL; Lau CS; Tse HF
    Clin Exp Rheumatol; 2012; 30(3):345-50. PubMed ID: 22409930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Rheumatic Diseases and Outcomes Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Ang SP; Chia JE; Misra K; Krittanawong C; Iglesias J; Gewirtz D; Mukherjee D
    Angiology; 2024 May; ():33197241255167. PubMed ID: 38771845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population.
    Ramirez M; Quintana G; Diaz-Gallo LM; Caminos J; Garces M; Cepeda L; Rondon F; Restrepo JF; Egea E; Garavito G; Robledo G; Martin J; Iglesias-Gamarra A
    Clin Exp Rheumatol; 2012; 30(4):520-4. PubMed ID: 22704547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serological hallmarks of systemic sclerosis overlap syndromes.
    Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP
    J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fact not to ignore: Mean blood pressure is the main predictor of increased arterial stiffness in patients with systemic rheumatic diseases.
    Čypienė A; Dadonienė J; Miltinienė D; Rinkūnienė E; Rugienė R; Stropuvienė S; Badarienė J; Laucevičius A
    Adv Med Sci; 2017 Sep; 62(2):223-229. PubMed ID: 28500898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition.
    Kakuta K; Dohi K; Sato Y; Yamanaka T; Kawamura M; Ogura T; Nakamori S; Fujimoto N; Fujii E; Yamada N; Ito M
    J Am Soc Echocardiogr; 2016 Feb; 29(2):173-80. PubMed ID: 26443046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.